Rascati, Karen L.; Johnsrud, Michael T.; Crismon, M. Lynn; … - In: PharmacoEconomics 21 (2003) 10, pp. 683-697
Objective: To examine both schizophrenia-related costs and total (schizophrenia plus non-schizophrenia) healthcare costs among Texas Medicaid recipients who had been diagnosed with a schizophrenic disorder and had been initiated on olanzapine or risperidone. Methods: Cost data for services and...